|

Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain

RECRUITINGN/ASponsored by Ankara Etlik City Hospital
Actively Recruiting
PhaseN/A
SponsorAnkara Etlik City Hospital
Started2026-02-16
Est. completion2026-08-16
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07445386

Summary

This study aims to compare the efficacy of fluoroscopy-guided paravertebral (PV) and transdiscal (TD) approaches for splanchnic nerve neurolysis in patients with upper abdominal cancer-related pain (e.g., gastric, pancreatic, and hepatic malignancies). Treatment response will be assessed using the Numerical Rating Scale (NRS), and the impact of both techniques on quality of life will be evaluated with the EORTC QLQ-C30 questionnaire.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Severe abdominal pain (NRS \> 6) due to upper intra-abdominal organ malignancies (such as gastric, pancreatic, or hepatic cancer).
* Failure of pain control with conservative treatment modalities.

Exclusion Criteria:

* Presence of local anatomical variations
* Localized or systemic infection involving the procedural site
* Pregnancy
* Coagulopathy
* Presence of unstable psychiatric disorders

Conditions4

CancerCancer PainLiver CancerLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.